Business | Tissuepathology.com

Proscia: What Proscia’s Top KLAS Ratings Mean for Life Sciences Companies

Erica Goodpaster — Fri, 13 Mar 2026 14:34:12 +0000

The latest from the Proscia blog: By Ritida Nanda | March 12, 2026 Proscia has been named Global 2026 Best in KLAS for Digital Pathology in Europe and earned the top performance score in the U.S. in the 2026 KLAS Digital Pathology Report. Here’s why life sciences organizations should take notice. Every clinical trial with a […]

The post Proscia: What Proscia’s Top KLAS Ratings Mean for Life Sciences Companies first appeared on Tissuepathology.com.

Indica Labs: KLAS Recognition as a Catalyst for What Comes Next

Erica Goodpaster — Wed, 25 Feb 2026 13:01:39 +0000

From the Indica Labs blog: We are proud to mark a significant milestone: HALO AP® earned 94.9/100* for overall customer rating in the 2026 Best in KLAS Awards – Global Software report for digital pathology. Because KLAS distinction is driven entirely by direct customer feedback, this recognition reflects the real-world performance, reliability, and impact of our platform in […]

The post Indica Labs: KLAS Recognition as a Catalyst for What Comes Next first appeared on Tissuepathology.com.

Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale

Erica Goodpaster — Wed, 14 Jan 2026 12:57:22 +0000

BOSTON–(BUSINESS WIRE)–Modella AI, a leader in artificial intelligence for life sciences, today announced that it has been acquired by AstraZeneca, expanding the companies’ existing collaboration to advance the application of multi-modal AI foundation models and AI agents across AstraZeneca’s global oncology portfolio. The acquisition follows a multi-year agreement with AstraZeneca announced in July 2025 and […]

The post Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale first appeared on Tissuepathology.com.

Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets

Erica Goodpaster — Thu, 18 Dec 2025 14:01:36 +0000

Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year, reinforcing its position as a market leader in digital pathology diagnostics. The company has been consistently profitable and […]

The post Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets first appeared on Tissuepathology.com.

A Philadelphia jury reached $35 million verdict against Main Line Health and Penn Medicine for cancer misdiagnosis

Erica Goodpaster — Mon, 08 Dec 2025 12:47:56 +0000

A woman underwent a total hysterectomy at Penn based on a cancer misdiagnosis at Lankenau Medical Center. The verdict is the largest so far this year in Philadelphia. A Philadelphia jury reached $35 million verdict last week against Main Line Health and the University of Pennsylvania Health System for a cancer misdiagnosis that led a […]

The post A Philadelphia jury reached $35 million verdict against Main Line Health and Penn Medicine for cancer misdiagnosis first appeared on Tissuepathology.com.

From Microscopes to Multimodal AI: A Conversation With Ben Cahoon of Techcyte

Erica Goodpaster — Thu, 27 Nov 2025 14:56:29 +0000

From Techcyte: Join us for this Thought Leaders episode as Ben Cahoon, CEO of Techcyte, discusses how the company’s Fusion Platform is redefining digital pathology — bringing together anatomic and clinical pathology into a single, AI-powered workflow. Hosted by Jonathan Tunstall, CEO and Founder of Pathology News, this Thought Leaders episode features an exclusive interview with: Ben Cahoon, CEO of Techcyte In this conversation, […]

The post From Microscopes to Multimodal AI: A Conversation With Ben Cahoon of Techcyte first appeared on Tissuepathology.com.